These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8853492)

  • 21. [Diagnosis of localized prostate cancer: screening and preoperative staging].
    Hammerer P; Huland H
    Urologe A; 1991 Nov; 30(6):378-86. PubMed ID: 1722921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Early diagnosis of prostatic cancer with digital rectal examination, PSA determination, and endorectal echography. Correlations with the morphologic diagnosis in 200 consecutive cases].
    Voisin E; Piaton E; Rivain T; Duco F
    Prog Urol; 1992 Dec; 2(6):973-9. PubMed ID: 1284556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early detection of prostate cancer with PSA: the Washington University experience.
    Smith DS
    Can J Oncol; 1994 Nov; 4 Suppl 1():57-62. PubMed ID: 8853491
    [No Abstract]   [Full Text] [Related]  

  • 24. The American Cancer Society's National Prostate Cancer Detection Project.
    Littrup PJ
    Can J Oncol; 1994 Nov; 4 Suppl 1():65-9. PubMed ID: 8853493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PSA and early prostate cancer detection: the importance of age-specific reference ranges.
    Oesterling JE
    Can J Oncol; 1994 Nov; 4 Suppl 1():52-6. PubMed ID: 8853490
    [No Abstract]   [Full Text] [Related]  

  • 26. Population-based analysis of prostate-specific antigen (PSA) screening in younger men (<55 years) in Australia.
    Ranasinghe WK; Kim SP; Lawrentschuk N; Sengupta S; Hounsome L; Barber J; Jones R; Davis P; Bolton D; Persad R
    BJU Int; 2014 Jan; 113(1):77-83. PubMed ID: 24053128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening.
    Catalona WJ; Smith DS; Ratliff TL; Basler JW
    JAMA; 1993 Aug; 270(8):948-54. PubMed ID: 7688438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current status and problems of a screening for prostatic cancer in the health facilities in Fukuoka Prefecture].
    Naito S; Kotoh S; Kumazawa J; Omoto T; Itoh K; Hatachi K; Shimizu Y; Yokoyama J; Nagayoshi H; Sagiyama K
    Nihon Hinyokika Gakkai Zasshi; 1993 Jul; 84(7):1227-35. PubMed ID: 7689121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of digital rectal examination on serum prostate-specific antigen in a primary care setting. The Internal Medicine Clinic Research Consortium.
    Arch Intern Med; 1995 Feb; 155(4):389-92. PubMed ID: 7531426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of DRE in the diagnosis of prostate carcinoma.
    Chong WL; Sahabudin RM; Teh GC; Woo SY; Lim TC; Khairullah A
    Med J Malaysia; 2001 Jun; 56(2):167-73. PubMed ID: 11771076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate carcinoma.
    Andriole GL; Catalona WJ
    Annu Rev Med; 1994; 45():351-9. PubMed ID: 7515219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
    Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
    J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Echography and follow-up of prostate carcinoma: "follow up echography in the course of drug therapy"].
    Martino P; Disabato G; Ditonno P; Battaglia M; Traficante A; Selvaggi FP
    Arch Ital Urol Androl; 1996 Dec; 68(5 Suppl):37-42. PubMed ID: 9162371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate cancer and prostate specific antigen. A Jamaican perspective.
    Douglas LL
    West Indian Med J; 1999 Jun; 48(2):47-9. PubMed ID: 10492600
    [No Abstract]   [Full Text] [Related]  

  • 35. Recommendations from the BC Office of Health Technology Assessment.
    Bassett K
    Can J Oncol; 1994 Nov; 4 Suppl 1():86-8; discussion 89-95. PubMed ID: 8853499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening and early detection of prostate cancer will decrease morbidity and mortality from prostate cancer: the argument against.
    Hall RR
    Eur Urol; 1996; 29 Suppl 2():24-6. PubMed ID: 8717457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer: screening and early detection update.
    Berger NS
    Semin Oncol Nurs; 1993 Aug; 9(3):180-3. PubMed ID: 7692577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lest we abandon digital rectal examination as a screening test for prostate cancer.
    Basler JW; Thompson IM
    J Natl Cancer Inst; 1998 Dec; 90(23):1761-3. PubMed ID: 9839511
    [No Abstract]   [Full Text] [Related]  

  • 39. Early detection of prostate cancer: the nature of cancers detected with current diagnostic tests.
    Ohori M; Scardino PT
    Semin Oncol; 1994 Oct; 21(5):522-6. PubMed ID: 7524152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determining overdiagnosis by screening with DRE/TRUS or PSA (Florence pilot studies, 1991-1994).
    Ciatto S; Gervasi G; Bonardi R; Frullini P; Zendron P; Lombardi C; Crocetti E; Zappa M
    Eur J Cancer; 2005 Feb; 41(3):411-5. PubMed ID: 15691641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.